You are here
Home > Clinical > New list of approved scheduled drugs for optometrists

New list of approved scheduled drugs for optometrists

Introduction

The Minister of Health has, in terms of section 22A(2) of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), on the recommendation of the South African Health Products Regulatory Authority (SAHPRA), made and updated the Schedules as per Government Notice R.220 (Medicines and Related Substances Act, 1965: Schedules) in, Government Gazette 43051, 28 February 2020.

The following is the list of new approved scheduled drugs for optometrists:

Schedule 1

SYMPATHOMIMETIC

Substance: Phenylephrine
Indication: Minor ocular irritation
Route of Administration: Topical (Drops)

Schedule 3

BETA -BLOCKER
Substance : Betaxolol
Indication : Open -Angle Glaucoma in Adults
Route of Administration Topical Application (Drops)

SYMPATHOMIMETIC

Substance: Brimonidine
Indication Open -Angle Glaucoma in Adults
Route of Administration :Topical Application (Drops)

BETA- BLOCKER

Substance: Levobunolol
Indication Open -Angle Glaucoma in Adults
Route of Administration : Topical Application (Drops)

Schedule 4

ANTIBACTERIAL
Substance: Tetracycline
Indication: Trachoma
Route of Administration: Oral

ANTIBACTERIAL
Substance: Doxycycline
Indication :Trachoma
Route of Administration : Oral

ANTIBACTERIAL
Substance : Azithromycin
Indication : Trachoma
Route of Administration: Oral

OPTOMETRIST (Bachelors degree in Optometry – B OPTOM) registered with the Health Professions Council of South Africa (HPCSA) in terms of the Health Professions Act, 1974 (Act 56 of 1974) and [in possession of a Section 22A(15) permit as provided for by the Medicines and Related Substances Act, 1965 (Act 101 of 1965)[ recognised by the HPCSA as an authorised prescriber.

Table 1. Schedule of approved pharmaceutical agents for Optometrists.
(
P Ramkissoon, 2020)

SCHEDULE 0
ANALGESIC
Substance Paracetamol
Indication Mild Pain
Route of administration Oral
SCHEDULE 1
ANALGESIC/ANTI-INFLAMMATORY
Substance Ibuprofen
Indication Mild to Moderate pain
Route of administration Oral
SYMPATHOMIMETIC
Substance Phenylephrine
Indication Minor ocular irritation
Route of administration Topical (Drops)
SCHEDULE 2
ANTIBACTERIAL
Substance Mupirocin
Indication Impetigo(Eyelids),External Hordeolum, Infected atopic dermatitis
Route of administration Topical application
ANTIHISTAMINE/VASOCONSTRICTOR/MAST CELL STABILISER
Substance Antazoline
Indication Allergic and Atopic Conjunctivitis
Route of administration Topical application
ANTIHISTAMINE/VASOCONSTRICTOR/MAST CELL STABILISER
Substance Tetrazoline
Indication Minor ocular irritation, red eye
Route of administration Topical application
ANTIHISTAMINE/VASOCONSTRICTOR/MAST CELL STABILISER
Substance Oxymetazoline
Indication Minor ocular irritation, red eye
Route of administration Topical application
ANTIHISTAMINE/VASOCONSTRICTOR/MAST CELL STABILISER
Substance Cetrizine, Loratidine, Levocetirizine
Indication Atopic dermatitis involving the eyelids
Route of administration Oral
ANTIHISTAMINE/VASOCONSTRICTOR/MAST CELL STABILISER
Substance Sodium Cromoglycate
Indication Vernal Keratoconjunctivitis
Route of administration Topical application
STEROIDAL ANTI-INFLAMMATORY
Substance Hydrocortisone
Indication Dermatitis, Ectopic or Seborrhoeic Eczema
Route of administration Topical application
SCHEDULE 3
CYCLOPLEGICS
Substance Atropine
Indication Cycloplegic refraction, Treatment of Uveitis
Route of administration Topical application (drops)
MYDRIATICS/CYCLOPLEGICS
Substance Tropicamide
Indication Cycloplegic, Mydriatic
Route of administration Topical application (drops)
MYDRIATICS/CYCLOPLEGICS
Substance Cyclopentolate
Indication Cycloplegic, Mydriatic
Route of administration Topical application (drops)
MYDRIATICS/CYCLOPLEGICS
Substance Homatropine
Indication Cycloplegic, Mydriatic
Route of administration Topical application (drops)
ANTI-GLAUCOMA
Substance Pilocarpine
Indication Acute Glaucoma
Route of administration Topical application (drops)
ANTI-GLAUCOMA
Substance Timolol
Indication Acute Glaucoma
Route of administration Topical application (drops)
BETA BLOCKER
Substance Betaxolol
Indication Open -Angle Glaucoma in Adults
Route of administration Topical Application (Drops)
SYMPATHOMIMETIC
Substance Brimonidine
Indication Open -Angle Glaucoma in Adults
Route of administration Topical Application (Drops)
BETA-BLOCKER
Substance Levobunolol
Indication Open-Angle Glaucoma in Adults
Route of administration Topical Application (Drops)
SCHEDULE 4
ANTIBACTERIAL
Substance Chloramphenicol
Indication Bacterial conjunctivitis, Anterior blepharitis,Posterior blepharitis
Route of administration Topical application
ANTIBACTERIAL
Substance Tetracycline
Indication Chlamydial conjunctivitis, Blepharitis
Route of administration Topical application
ANTIBACTERIAL
Substance Erythromycin
Indication Chlamydial conjunctivitis, Blepharitis, Impetigo
(Not to be used as 1st line of treatment)
Route of administration Topical application
Substance Tetracycline
Indication Trachoma
Route of administration Oral
Substance Doxycycline
Indication Trachoma
Route of administration Oral
Substance Azithromycin
Indication Trachoma
Route of administration Oral
ANTIVIRAL
Substance Acyclovir
Indication Conjunctivitis, Herpes simplex blepharitis, Epithelial keratitis
Route of administration Topical application
LOCAL ANAESTHETIC
Substance Tetracaine
Indication Diagnostic aid
Route of administration Topical application (drops)
LOCAL ANAESTHETIC
Substance Oxybuprocaine and other equivalent LAs
Indication Diagnostic aid
Route of administration Topical application (drops)

These Schedules as amended has come into operation on the date of publication in the Government Gazette (28/02/2020). The South African Optometric Association (SAOA) has requested the Practice Code Numbering System (PCNS), a division of the Board of Healthcare Funders (BHF) to ringfence practitioners who have Ocular Therapeutics recognition and appear on the HPCSA register by allocating an intelligent code within the existing practice numbering system to facilitate the payment of claims by medical schemes for professional services rendered.    

Reference

1. Government Notice R.220 (Medicines and Related Substances Act, 1965: Schedules) in, Government Gazette

Share on Facebook

Top